Stephanie Graff, MD, concludes the discussion with thoughts on endocrine therapies in development for patients with ER+/HER2- metastatic breast cancer.
Stephanie L. Graff, MD
Advertisement
Articles by Stephanie L. Graff, MD
An expert on breast cancer reviews currently available tests for ESR1 mutations and provides clinical insights on best practices for testing.
Stephanie L. Graff, MD, provides an overview of ESR1 mutations in ER+/HER2- metastatic breast cancer, highlighting their prevalence, clinical implications, and challenges.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
2
Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains
3
Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM
4
Defunding Co-Payment Assistance Disrupted nAMD Care
5